Use of a Physiologically Based Pharmacokinetic Model for Rats to Study the Influence of Body Fat Mass and Induction of CYP1A2 on the Pharmacokinetics of TCDD

Environmental Health Perspectives - United States
doi 10.1289/ehp.8805
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Environmental Health Perspectives


Related search